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Abstract
Background: Fine needle aspiration (FNA) cytopathology is the gold standard work-up for thyroid nodules.
However, indeterminate lesions are encountered commonly and can lead to difficult treatment decisions. We
sought to determine whether patients experienced decisional conflict surrounding management with diagnostic
thyroidectomy in the setting of indeterminate FNA results.
Methods: Patients with indeterminate results of thyroid nodule FNA were prospectively enrolled. All consultations
were carried out by three otolaryngologists in a consistent manner. After consultation, participants completed a
demographics form and the Decisional Conflict Scale (DCS) questionnaire.
Results: Thirty-five patients (28 female) between the ages of 30 and 88 years (mean age 54.89) participated. The
median total DCS score was 10.94 (interquartile range, 4.69–25.0). Twelve patients (34 %) scored at or above 25 on
the DCS, indicating clinically significant level of decisional conflict. Patients reported feeling significantly more
confident about their decision after the surgical consultation compared to before the consultation (p = 0.00).
The total DCS score was significantly negatively correlated with self-reported confidence after the consultation
(r = −0.421, p = 0.012).
Conclusion: Many patients experienced clinically significant decisional conflict when considering thyroidectomy for
management of a thyroid nodule with indeterminate cytopathology. Future research should be directed at
developing decision support tools for this patient group, and exploring the impact of decisional conflict on health
outcomes.
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Background
Thyroid cancer has demonstrated the most rapid in-
crease in incidence of any cancer in North America, and
now ranks as the fifth most common cancer in women
[1, 2]. Part of the increase is attributed to early detec-
tion, often incidentally, through improved diagnostic im-
aging techniques [3–5].
One of the most important diagnostic tools for sus-
pected thyroid cancer is the fine needle aspirate (FNA).
The FNA is performed for most thyroid nodules greater
than 1.5 cm, or smaller in patients with suspicious sono-
graphic features or those with high-risk history [6]. Over
500,000 thyroid nodule FNA procedures are performed
annually in the United States [7]. The sample obtained
via FNA is analyzed cytopathologically and reported at
most institutions with the guidance of the Bethesda
Grading System [8]. The Bethesda system describes six
categories: nondiagnostic or unsatisfactory, benign, aty-
pia of undetermined significance (AUS) or follicular le-
sion of undetermined significance (FLUS), follicular
neoplasm or suspicious for a follicular neoplasm (SFN),
suspicious for malignancy (SFM), or malignant [8].
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Indeterminate results include AUS, FLUS, and SFN,
which are encountered in about 15–30 % of samples,
and carry a 6–32 % risk of malignancy [7, 9, 10]. Practice
guidelines have traditionally recommended surgery for
indeterminate lesions; however, final pathology yields a
benign result in 70–85 % of cases [7].
Patients with indeterminate results on FNA who are
considering diagnostic thyroidectomy may face chal-
lenges in decision-making because of limited consult-
ation time with surgeons, complexity of information on
risks/benefits, and the uncertainty of their diagnosis. As
a result, patients may experience decisional conflict,
which can lead to emotional distress and other negative
sequelae [11, 12]. Tools such as decision aids can help
patients and practitioners become more involved in
decision-making by providing information about treat-
ment options and outcomes, clarifying personal values
about the treatment, and providing guidance throughout
the decision-making process. The use of decision aids
has been shown to result in a range of favorable out-
comes including less decisional conflict, improved pa-
tient knowledge, and greater concordance between
patient values and chosen treatment option [13]. As well,
the use of decision aids can lead to reduction in un-
necessary variation in care and costs across different
healthcare regions [14]. In fact, there is a sleeper
provision in the Affordable Care Act (Section 3506) that
encourages the use of shared decision-making in health-
care with decision aids. Before a decision aid can be ap-
propriately developed, a decision-needs analysis is first
required, which includes measuring the level of deci-
sional conflict in certain procedures.
There is a paucity of data in the literature surrounding
decisional conflict and to date, none are available for
diagnostic thyroidectomy. The purpose of this study was
to assess the level of decisional conflict in patients with
an indeterminate result on thyroid nodule FNA who are
considering thyroidectomy. We also evaluated the rela-
tionship between patient factors and decisional conflict
Methods
All adult patients who received an indeterminate result
on thyroid FNA during the study period (January 2014
to June 2014) were invited to participate in this study.
The only exclusion criteria was the inability to speak or
read English (n = 0) or the lack of decision-making au-
thority (n = 0). Also, patients who had multiple FNAs of
the same thyroid nodule were also excluded (n = 4). All
patients were being considered for diagnostic hemi-
thyroidectomy.
Patients were approached after the consultation visit
with their head and neck surgeon where they were in-
formed of their indeterminate FNA results. Informed
consent for inclusion in this study was obtained from all
those who agreed to participate. Each patient was asked
to complete a Demographic/Condition form and the De-
cisional Conflict Scale (DCS).
For providers, three head and neck fellowship trained
otolaryngologists participated. All used a consistent
script to ensure that similar information was shared dur-
ing the visit.
Local Institutional Review Board approval was ob-
tained for this study.
Demographic/condition form
The demographic information collected on this form in-
cluded patient age, family composition, employment sta-
tus, occupation and income. Data was also collected on
previous surgical experience, confidence level in their
medical decision-making before and after the consult-
ation, how well they usually handle medical appoint-
ments, and whether they were aware that surgery was an
option before presenting.
Decisional conflict scale (DCS)
This 16-item scale assesses patient uncertainty about
medical decisions. It is a Likert scale with ratings of
strongly agree, agree, neither agree or disagree, disagree,
and strongly disagree. The DCS produces a total score
ranging from 0 (no decisional conflict) to 100 (maximal
decisional conflict). Five Subscales scores are also pro-
duced. The subscales are interpreted as follows: uncer-
tainty subscale [scores range from 0 (extremely certain
about best choice) to 100 (extremely uncertain about
best choice)], informed subscale [0 (feels extremely in-
formed) to 100 (feels extremely uninformed)], values clarity
subscale [0 (feels extremely clear about personal values for
benefits and risks) to 100 (feels extremely unclear about
personal values)], support subscale [0 (extremely supported
in decision making) to 100 (extremely unsupported in
decision making)], and effective decision-making subscale
[0 (good decision) to 100 (bad decision)] [16].
The DCS is a validated scale that is designed to be
context non-specific. It has demonstrated high test-
retest reliability and high content validity, as scores on
the DCS were higher for patients who delayed or were
unsure of their decision in comparison to those who ac-
cepted or rejected treatments [16]. Previous research has
defined clinically significant decisional conflict as a DCS
score at or above 25 [16].
Data analysis
The DCS scores were not normally distributed; there-
fore, nonparametric statistical tests were used. Descrip-
tive statistics including median, interquartile range
(IQR), and standard error (SE) of the total DCS scores
are reported. The DCS subscale scores along with the
number of patients with total DCS score at or above 25,
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indicating clinically significant decisional conflict, are
also reported. The relationship between baseline fac-




The study was conducted at a head and neck oncology
clinic situated in a tertiary care academic hospital in
Eastern Canada. Thirty-five new consecutive patients
who met the inclusion criteria were invited to participate
in this study. All patients approached agreed to partici-
pate. None of the patients had other diagnostic testing
(e.g., molecular testing or gene profile analysis).
Patients ranged in age from 30 to 88 years (mean =
54.89, SD = 15.30). Twenty-eight (80 %) patients were
female and 7 (20 %) were male. Twenty-eight (80 %) pa-
tients had undergone previous surgery in the past, and
19 (68 %) of those had undergone more than one. The
most common operations reported were tonsillectomy
(n = 7), gynecological procedures (n = 6), cesarean sec-
tion (n = 5), breast surgery (n = 5), and cholecystectomy
(n = 4). Twenty (57 %) patients had family members who
had undergone previous surgery. All patients reported
that they had handled previous medical visits well (n = 9)
or very well (n = 26). Most patients (n = 33, 94 %) re-
ported that they knew surgery was an option prior to
the consultation visit, while one patient was unaware
(data was unavailable for one participant).
Three head and neck fellowship trained otolaryngolo-
gists, ranging in age from 36 to 46 years, participated.
All were male. All were in a salaried academic practice
and all trained in North America.
Decisional conflict
The median total DCS score was 10.94 (SE = 3.01, IQR =
4.69–25). Twelve patients (34 %) were found to have clin-
ically significant decisional conflict, as they scored at or
above 25 on the DCS (Fig. 1). Three patients (8.5 %)
scored zero on the DCS, indicating no uncertainty about
their decision. Summary of the DCS results is presented
in Table 1.
There were no significant differences in the total DCS
scores or subscale scores based on whether the patient
had previous surgery or if another family member had
previous surgery. As well, no significant correlation
existed between DCS scores and patient income, patient
gender, or previous awareness of surgery. However, there
was a significantly negative correlation between values
clarity subscale scores and patients’ self-report of how well
they tolerated previous surgery (r = −0.347, p = 0.041). As
well, patient age and support subscale scores were signifi-
cantly positively correlated (r = 0.382, p = 0.023).
Patients’ self-reported confidence levels were signifi-
cantly higher after surgical consultation (mean = 7.11
out of 10) compared to before consultation (mean = 6.43
out of 10; p = 0.00). The total DCS score was signifi-
cantly negatively correlated with confidence level after
consultation (r = −0.421, p = 0.012).
Discussion
It is estimated that 15–30 % of FNA samples yield inde-
terminate results, of which 70–85 % are diagnosed to be
benign after thyroidectomy [3, 4]. In light of this uncer-
tainty, patients may experience decisional conflict when
faced with the decision to proceed with diagnostic sur-
gery. In the current study, the median total DCS score
was 10.94. However, 12 (34 %) individuals scored at or
above the cutoff score of 25, indicating the presence of
clinically significant decisional conflict. This level of deci-
sional conflict is similar to previous studies that have
assessed other elective surgical procedures [12, 15, 18–23].
Given the high prevalence of indeterminate thyroid lesions,
the number of patients experiencing decisional conflict
may be substantial. Decisional conflict is associated with
negative outcomes such as emotional distress, cancelled
surgeries, and non-adherence to treatment plans [12]. To
overcome this problem, an approach is needed to help
both healthcare providers and their patients in surgical
decision-making.
Shared decision-making is a strategy that could be used
in the current patient population. This is an approach that
requires collaboration between healthcare providers and
their patients to understand the treatment options and
have knowledge of the risks and benefits of these options.
At the same time, shared decisions should consider the
patients’ own preferences and values in decision-making
[17]. The importance of shared decision-making goes well
beyond reducing decisional conflict and the associated
negative outcomes. This includes improved quality of care
and reduced variation in care and costs across different re-
gions since there is a more consistent decision-making
process and better compliance with clinical guidelines
[15]. As mentioned above, there is a provision in the Af-
fordable Care Act that encourages the use of shared
decision-making in healthcare [24]. Unfortunately, the
concept of shared decision-making in medicine is in its in-
fancy at this time.
To date, no studies have assessed the level of decisional
conflict in patients considering diagnostic thyroidectomy.
However, a decisional conflict analysis was performed on
patients considering adjuvant radioactive iodine treatment
for early stage papillary thyroid cancer as part of a ran-
domized control trial assessing the utility of a decision aid.
The mean total DCS score was very high (52.1, SD = 21.9)
in those patients deciding on whether to accept or reject
the radioactive iodine treatment [18]. Clearly, significant
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decisional conflict is prevalent in patients who are under-
going work-up and treatment of thyroid nodules and
malignancies.
There are other studies reporting decisional conflict in
patients undergoing work-up and treatment of malig-
nancies. Women diagnosed with ductal carcinoma in
situ of the breast were found to have a mean total DCS
score of 20.5 with 47 % reporting clinically significant
decisional conflict when considering various treatment
options [19]. Another study with breast cancer patients
faced with surgical decisions reported a mean total DCS
score of 19.9 [20]. Studies in patients dealing with pros-
tate cancer screening and pre-treatment decisions found
a mean total DCS score of 25 [21] and 53 [22], respect-
ively. Again, these data indicate that decisional conflict
is common in patients with common malignancies.
Subscale analysis of the DCS showed that the uncertainty
and values clarity subscales had the highest levels of deci-
sional conflict. The informed and support subscales had
the lowest levels of decisional conflict. Patient age and sup-
port subscale scores were significantly positively correlated,
indicating that older patients were more likely to have less
support in their decision-making. This is an important
finding as older patients without adequate social or family
support may be at higher risk of having significant
decisional conflict. Therefore, clinicians may need to pro-
vide additional decision support to some older patients.
A significant negative correlation existed between values
clarity subscale scores and patients’ self-report on how
well they handled previous surgeries. This indicates that
patients were more likely to feel clearer about personal
values for the benefits and risks of surgery if they did not
handle previous operations well. One would expect that a
patient with positive previous surgical experience would
be more familiar and perhaps more insightful to their per-
sonal values regarding surgery. However, the converse was
noted in the current study. The explanation for this find-
ing is unclear but the modest nature of the correlation
should be iterated (r = −0.347, p = 0.041).
Patients were significantly more confident in their
decision-making after the surgical consultation, com-
pared to before. This was a reassuring finding that con-
sultation with surgeons, which involved a detailed
discussion of the risks and benefits of the diagnostic sur-
gery, had a positive effect on the decision-making
process. However, it is to be noted that the change in
confidence level (6.43 to 7.11 out of 10) was small and
the clinical significance remains unclear. Therefore, ef-
fect size calculation with increased sample size is re-
quired to make a more definitive conclusion.
Table 1 Median total decisional conflict scale and subscale scores
Total Uncertainty Informed Clarity Support Effective
Median 10.94 25.00 8.33 25.00 8.33 12.50
SE 3.01 3.23 2.32 2.57 2.08 2.27
IQR 4.69–25 8.33–25 0.00–25 0.00–25 0.00–25 0.00–25
Abbreviations: SE standard error, IQR interquartile range
Fig. 1 Frequency of total Decisional Conflict Scale scores. Scores to the right of the red line (≥25) indicate clinically significant decisional conflict
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Unsurprisingly, the total DCS score was significantly
negatively correlated with self-reported confidence level
after the consultation visit. Although causation cannot
be proven, this suggests that most individuals felt more
confident after the consultation, which may have con-
tributed to lower levels of decisional conflict.
Decision aids are evidence-based tools used to support
patients in challenging medical decision-making situa-
tions (i.e., when there isn’t one superior treatment op-
tion). Decision aids have been shown to improve patient
knowledge, enhance shared decision-making, increase
the number of patients with realistic ideas about the
risks and benefits of a medical procedure, and reduce
decisional conflict [23]. They can also empower the pa-
tient with information to facilitate a more meaningful
and informed discussion with their physician [24]. Deci-
sion aids usually include three sections: 1) a description
of the health condition and management options being
considered; 2) a summary of the evidence for each of
these options including risks and benefits; 3) and an
element to help the patient consider this information in
the context of their personal values [25].
In oncology, decision aids have been used in cancer
patients considering surgical intervention with good suc-
cess. In a meta-analysis, O’Brien et al. found that the use
of decision aids in cancer related illness leads to signifi-
cantly improved knowledge about screening, treatment,
and preventative measures compared to usual practice
[26]. Overall, the use of well-developed decision aids led
to reduced decisional conflict and no increase in general
anxiety [26]. Further support for decision aids comes
from randomized controlled trials in patients with thy-
roid, breast, and prostate malignancies. Decisional con-
flict was significantly reduced in patients given decision
aids, compared to those who underwent conventional
consultation [18, 19, 21, 22]. Although there are many
positive aspects, no comprehensive evidence-based deci-
sion aids exist in otolaryngology at this time [25].
Clearly, decision support tools, such as decision aids,
would benefit patients with indeterminate thyroid nod-
ule FNA results.
There has been a recent call for the development of
decision aids in otolaryngology as there are many elect-
ive surgical procedures within this specialty (e.g., tonsil-
lectomy, sinus surgery, rhinoplasty) [25, 27]. Although
there are numerous processes reported for developing
decision aids [28], the most rigorous and well-received
method is best practices recommended by the Inter-
national Patient Decision Aid Standards (IPDAS) Collab-
oration [29]. The IPDAS framework outlines an iterative
process, which allows multiple stakeholders (e.g., pa-
tients, clinicians, decision experts) to define their needs
so that the decision aid will be feasible and useful to all
potential users. Even though there are a number of
decision aids currently available, many have been devel-
oped without following a specific methodology, which
can lead to poor quality and information presented in a
biased manner [28]. Therefore, decision aids in otolaryn-
gology and beyond should be created following the
method outlined by the IPDAS Collaboration.
Limitations of this study include the involvement of
multiple head and neck surgeons. This caused an inherent
variability of approach to patients and counseling style,
perhaps resulting in different experiences for patients. To
control for this, the surgeons used a semi-structured inter-
view script to keep the delivered information consistent
(i.e., same risks and benefits discussed). Unfortunately, the
sample size did not allow for direct statistical comparison
of the DCS scores between surgeons. The use of multiple
providers does, however, allow for a more broad perspec-
tive of the decisional conflict that exists across the patient
population. The second limitation of this study is the con-
sideration of only indeterminate thyroid lesions. More in-
formation regarding decisional conflict could be gleaned
from comparison of all FNA results. Third, the long-term
influence of clinically significant decisional conflict is un-
known in our study population. That is, some patients
with decisional conflict may have been less satisfied with
their overall experience or may have changed their deci-
sion over time. Fourth, some demographic information
was not measured (e.g., education levels, ethnicity) that
may have influenced the level of post-consultation deci-
sional conflict. Finally, the sample size of the participants
was small, but was comparable to other studies assessing
decisional conflict [12, 15, 18–22, 30].
To advance research in this area, future studies should
consider incorporating observations of consultation
visits (e.g., video-recording) of a larger number of pro-
viders across multiple healthcare centers. Moreover, re-
search should assess long-term outcomes of decisional
conflict including knowledge about the procedure and
postoperative care. Finally, as mentioned above, future
research should aim to identify strategies that could im-
prove the decision making process for patients (and pro-
viders) with the potential aim of developing decision
support tools, such as decision aids.
Conclusion
Many patients with indeterminate thyroid FNA results
experienced clinically significant decisional conflict and
therefore were uncertain about their decision to proceed
with diagnostic thyroidectomy. Decisional conflict has
been associated with many negative outcomes, and
therefore future research should aim to find methods to
reduce decisional conflict.
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